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1. Summary 
The Mre11/Rad50/Nbs1-complex (MRN) is activated in response to DNA double-strand 
breaks (DSB). DSBs belong to the most toxic forms of DNA-damage, they lead to the activa-
tion of the DNA damage response (DDR), which ultimately results in the activation of cell 
cycle checkpoints, coordination of DNA repair mechanisms, induction of transcriptional pro-
grams or apoptosis and senescence if the damage is too severe. The two main DNA repair 
pathways to overcome DSBs are non-homologues end joining (NHEJ) and homologues re-
combination (HR). MRN is involved as sensor of DSBs, it binds to DSBs and is recruited to 
DSB-flanking chromatin compartments. Our lab has purified MRN and MR subcomplexes 
from Baculovirus-infected insect cells and our collaborator analysed these by single-particle 
electron microscopy (EM). The analysis revealed that the MR heterodimers were present as 
monomers, multimers and protein aggregates and it was not possible to separate and properly 
analyse them. Thus, the goal of this project was to isolate and purify MR heterodimers for 
subsequent EM analysis. For this, differentially-tagged Mre11 and Rad50 were co-expressed 
in insect cells and tandem purified. While the original goal was not achieved due to technical 
difficulties and time constraints, the result of this thesis revealed that polyhistidine-tagged 
Rad50 co-purifies with untagged Mre11, which indicates that these two human proteins form 
a complex when co-expressed in insect cells. 
 
 
Keywords: MRN, tandem purification, Baculovirus Expression System, DNA-Repair 
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2. Introduction 
3 billion base pairs of DNA form the human genome, a sensitive entity complex with various 
proteins and located in the cell nucleus. Even small alterations can cause serious consequences; 
therefore, the maintenance of the genome is of great importance for a cell. Through a single mu-
tation, severe developmental disorders or cancer formation can occur. The cells in all organisms 
are constantly under influence of endogenous and exogenous agents like ultraviolet light, ioniz-
ing radiation and genotoxic agents that can induce DNA damage; if the induced damage is not 
repaired properly, mutations can occur (Hoeijmakers, 2001). 
 
If critical genes are mutated, cancer formation can be promoted (Vogelstein and Kinzler, 2004). 
In order to protect the genetic information from the deleterious effects of DNA damage, various 
mechanisms evolved in the cells to react in an appropriated manner. Many proteins are involved 
in the DNA damage response (DDR); they detect, signal the presence of, and repair DNA dam-
age. They also coordinate the cell cycle progression to ensure correct DNA replication and cell 
division. The response can lead to the activation of cell cycle checkpoints, DNA repair mecha-
nisms, transcriptional programs, apoptosis and senescence (Rupnik et al., 2010). On the level of 
the whole organism, unrepaired DNA damage can lead to immunodeficiency, premature aging 
and neurodegeneration (Ljungman, 2010). 
Various forms of DNA damage can occur; one of the most toxic forms is DNA double-strand 
breaks (DSBs) because both strands of the DNA are affected and thus, there is no intact strand 
left that can serve as a template for the repair synthesis. Several agents can lead to double-strand 
breaks, most prominent are ionizing radiation (IR) or radiomimetic chemicals, but also mechanic 
stress on chromosomes, products of collapsed replication forks, or even the physiological event 
of V(D)J recombination in B- and T-lymphocyte development can lead to DSB formation. The 
repair is so difficult because the structure of the DNA double helix is broken and even the short 
complementary overhangs cannot keep the DNA ends juxtaposed by base pairing and the ends 
may dissociate from each other if not held together by means of DNA end-binding protein com-
plexes. It has been shown that DSBs can lead to induction of mutations and chromosomal trans-
location, which are hallmarks of tumor cells (Jackson, 2002). 
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2.1. DNA double-strand breaks 
2.1.1. DSB repair mechanisms 
DSB repair mechanisms are highly conserved throughout evolution, they are found in phages, 
bacteria, yeast and higher eukaryotes (Cromie et al., 2001). Homologues recombination (HR) 
and non-homologues end joining (NHEJ) are two main repair pathways for DSBs. In mammali-
an cells, the HR predominates mainly in S- and G2 phases of the cell cycle when the undamaged 
sister chromatid can be used as a template, whereas NHEJ predominates in G0- and G1-phase 
(Shrivastav et al., 2008). 
 
2.1.2. Homologues recombination 
For the HR, homologous sequences in form of sister chromatids, homologous chromosomes or 
DNA repeats are required. It is considered an error-free repair pathway (Takata et al., 1998). 
First, the DNA ends are resected to yield 3’ single-stranded overhangs. This resection is initiated 
by the MRN complex and regulated by CtIP, an adaptor protein. The resection is then completed 
by the nuclease EXO1 and several helicases (Paull and Gellert, 1998). After resection, Rad52 
and Rad54 promote ATP-dependent homologous DNA pairing and strand exchange (Baumann 
et al., 1996; Gupta et al., 1997). RPA coats the ssDNA tails, Rad51 forms a complex with it and 
initiates strand exchange (Sung, 1997). BRCA2 interacts with Rad51 and RPA at DSBs and 
helps to load Rad51 onto the DNA (Yang et al., 2002). BRCA1 and BRCA2 are believed to be 
important at early steps of HR, perhaps because they coordinate DNA repair with other cellular 
processes. Following sister-chromatid pairing and strand invasion, two distinct pathways can be 
used. Favoured in mammalian cells is the non-crossing-over, it results from disengagement of 
the Holliday junction followed by DNA pairing and gap filling in the damaged homologue 
(Johnson and Jasin, 2000). In the classical path the Holliday junctions are resolved by endonu-
cleolytic cleavage and the probability of crossover or noncrossover are equal. Many factors that 
are involved in HR are essential. HR may be more important in embryonic cells than in normal 
adult somatic cells, and studies suggest that disruption of factors involved in HR result in chro-
mosomal instability and cancer predisposition (Thompson and Schild, 2001; van Gent et al., 
2001). (Figure 1B) 
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2.1.3. Non-homologues end joining 
NHEJ is the predominant repair mechanism in higher eukaryotes, but is not as accurate as HR. 
By adding or deleting nucleotides from free DNA ends, the strands are processed till the ends 
can be joined. For this process, no sister chromatid is needed (Budman and Chu, 2005). The Ku 
heterodimer that consists of Ku70 and Ku80 binds free DNA ends and recruits the DNA-PKcs, 
which then becomes activated (Martensson and Hammarsten, 2002). Analyses of the catalytic 
domains revealed DNA-PKcs to be a member of the phosphatidylinositol 3-kinase-like family 
(PIKK) that also includes ATM (ataxia telangiectasia mutated) and ATR (ATM related) (Hartley 
et al., 1995). Further studies showed different interactions of DNA-PKcs with other proteins like 
Artemis, which is activated through phosphorylation that induces an endonuclease hairpin open-
ing activity (Ma et al., 2002; Riha et al., 2006). Loss or mutation of DNA-PKcs leads to radio 
hypersensitivity and severe combined immunodeficiency. 
After recruitment of DNA-PK and DNA end processing by Artemis and perhaps MRN, the 
Lig4/XRCC4 along with XLF joins the two DNA ends and restores the DNA structure (Ma et 
al., 2002). (Figure 1A) 
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2.2. Cellular response to DNA double-strand breaks 
In addition to the activation of the repair pathways, also a global cellular response that involves 
the entire cell is activated by DSBs. This includes the regulation of cell cycle transitions, tran-
scriptional activation and apoptosis. First, sensor proteins detect the DSB and activate the ki-
nase-dependent signalling cascade. The DNA damage response (DDR) is a signal-transduction 
pathway with sensors, transducers and effectors. The signal is amplified and diversified so that 
one single DSB can lead to a full cell cycle arrest (Khanna and Jackson, 2001). 
ATM is a conserved signalling component with a central role in the cellular response to DSBs. 
Patients carrying two mutated ATM alleles manifest progressive cerebellar ataxia, immune defi-
ciencies, gonadal atrophy, oculocutaneous telangiectasias, radiation sensitivity, premature ageing 
and increased risk of cancer (Bakkenist and Kastan, 2003). ATM belongs like DNA-PKcs to the 
PIKK family; it gets recruited to DNA DSB by the MRN complex, consisting of Mre11, Rad50 
and Nbs1 (Stucki and Jackson, 2004; Falck et al., 2005). MRN accumulates rapidly at the dam-
aged site, its activation leads to ATM autophosphorylation on multiple residues. The thus gener-
ated ATM monomers phosphorylate different targets such as checkpoint kinase 2 (CHK2), me-
diator of DNA damage checkpoint 1 (MDC1), p53 binding protein 1 (53bp1), breast cancer sus-
ceptibility protein (BRCA1) and histone 2A variant X (H2AX). Not only the repair pathways 
can be activated and regulated by these phosphorylations, it can also lead to transient or perma-
nent cell cycle arrest if the damage persists, or to programmed cell death (apoptosis) when the 
DNA damage is too severe. The phosphorylation of H2AX leads to the recruitment of MDC1 to 
the site of DNA damage. MDC1 amplifies H2AX phosphorylation, maybe by recruiting ATM 
into the DSB-flanking chromatin compartment or by preventing dephosphorylation (Stucki and 
Jackson, 2006). For the interaction between MRN and MDC1, the FHA and the two BRCT do-
mains of Nbs1 are needed, mutations in either of them leads to defects in MRN accumulation 
(Hari et al., 2010). Many proteins are recruited to the modified chromatin regions flanking 
DSBs. These regions can be visualized by standard fluorescence microscopy as bright speckles, 
usually termed DNA damage foci or ionizing radiation-induced foci (IRIF). The DNA damage 
foci are composed of many different factors that are mainly recruited through MDC1 and phos-
phorylated H2AX. It was shown that MDC1 recruits Ubc13-Rnf8, an ubiquitin ligase complex 
that ubiquitinylates different chromatin components at DSBs, and their poly-ubiquitination is 
needed for the recruitment of 53bp1 and BRCA1 (Huen et al., 2007; Kolas et al., 2007; Mailand 
et al., 2007). ATM or CHK1 and CHK2 target the effector proteins such as p53 and Cdc25a. 
These are major effector proteins that are often mutated in cancer cells. p53 acts as a transcrip-
tion factor regulating expression of p21, a Cdk inhibitor protein responsible for G1 cell cycle ar-
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rest, and its accumulation can lead to apoptosis through activation of the caspase-signaling cas-
cade. Cdc25a acts as a phosphatase, removing the inhibitory phosphorylation on cyclin-
dependent kinases (Cdks). Upon targeting of Cdc25a by CHK1 and CHK2 it is degraded and 
thus, Cdks such as the S-phase driving Cdk2 remain inactive. 
In summary, DSBs can trigger different cellular responses dependent on the pathways that are 
activated. As mentioned above, one key player in the response to DSBs is the MRN complex, 
which was investigated in this thesis. 
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2.3. The MRE11/RAD50/NBS1 complex 
The MRN complex has many tasks in the cellular response to DSBs. It acts as a sensor of DSBs 
and activator of signal transduction, it can influence the DSB repair pathway selection to HR or 
NHEJ, it has a repair function in HR and NHEJ and it takes part in the telomere homeostasis 
(Lamarche et al., 2010). (Figure 2) 
 
 
Figure 2: MRN Complex (A) and binding to the DNA (B/C) 
(Reproduced from Kanaar. Cell, 2008) 
The MRN complex is normally present as M2R2N1. The Walker A/B domains of Rad50 and the Mre11 build the 
globular domain. While the Rad50 coiled-coil region build long arms (A). Upon DNA binding it comes to confor-
mational changes (B/C) 
 
2.3.1. Mre11 
The Mre11 protein forms a U-shaped dimer, which is required for DNA binding. It interacts with 
Rad50 via a C-terminal domain, flanked by two DNA binding regions. The Nbs1 interaction oc-
curs via an N-terminally located interaction domain. The nuclease activity is located within con-
served motifs in the N-terminal region (Rupnik et al., 2010). Mre11 can build up two structure 
type of interaction, first, the “synaptic DNA complex” mimicking DNA end joining with a 2bp 
3’ overhang on double-stranded oligonucleotides or second, the “branched DNA complex” that 
is formed between Mre11 and ‘Y-shaped’ oligonucleotides containing regions of both double 
and single-stranded DNA oligonucleotides. The binding is mediated entirely by minor groove 
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contacts to the sugar phosphate backbone, whereby Mre11 can work as a universal DNA end 
processing enzyme, since it doesn’t need a specific sequence to bind (Williams et al., 2008; 
Furuse et al., 1998). But it prefers to bind to ds-oligonucleotides than to ss-oligonucleotides, and 
longer DNA substrates are also favoured. It prefers 3’ overhangs to 5’ overhangs and in ds-
oligonucleotides, the binding is better with a cohesive overhang (Furuse et al., 1998; Usui et al., 
1998). Mre11 shows no activity with duplex linear or circular substrates (Moreau et al., 1999). 
For DNA binding the dimerization of Mre11 is important, while the endonuclease activity and 
the 3’ to 5’ exonuclease activity are not dependent on the high-affinity DNA binding through the 
dimerization (Williams et al., 2008). It was shown that the N-terminal phosphoesterase domain 
is not required for the nuclease activity (Furuse et al., 1998; Usui et al., 1998). The 3’ to 5’ exo-
nuclease activity is dependent on specific DNA-alignment, for the 3’ to 5’ exonuclease activity 
the Motif II is needed, while the Motif III is required for endonuclease and exonuclease activity 
(Williams et al., 2008; Moreau et al., 1999; Usui et al., 1998). The exonuclease shows a weak 3’ 
to 5’ activity on a linear duplex substrate with Mn2+ as a cofactor (Moreau et al., 1999), but is 
independent of ATP (Furuse et al., 1998). For the early HR the endonuclease activity is crucial, 
it acts with additional factors together to open DNA ends and produce an effective 5’ to 3’ exci-
sion that liberates 3’ ssDNA for RPA loading and initiation of strand invasion (Williams et al., 
2008; Usui et al., 1998). The Mre11 endonuclease activity plays an essential role in meiosis, 
were it probably removes Spo11 from 5’ends of double-strand break sites. For vegetative 
growth, mating type switching, NHEJ and telomere maintenance, the nuclease activity is dispen-
sable, because the DSBs can be processed by other nucleases, which act redundantly with Mre11 
(Moreau et al., 1999). (Figure 3) 
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Figure 3: Structure of Mre11  
(Reproduced from Rupnik, Chromosoma, 2010) 
The domain structure of Mre11 (a), the „capping domain“ is responsible for conformational changes upon DNA 
binding. Indicated with stars are mutations found in ataxia telangiectasia-like disorder (ATLD). Mre11 forms a U 
shaped dimer (b). Nbs1 interaction with Mre11 (c). Interaction types of Mre11 (d). 
 
2.3.2. Rad50 (MR) 
Rad50 is a member of the structural maintenance of chromosome (SMC) family, involved in 
chromosome condensation and sister-chromatid cohesion. Both termini contain Walker A and B 
motifs required for ATPase activity, DNA binding and partial DNA unwinding. Studies showed 
that mutations in the Walker A motif cause hypersensitivity to DNA damaging agents, which 
was as sensitive as Rad50 knockout. The mutants are compromised for HR and NHEJ. The 
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complex assembly is not defective in the mutant but the ATP hydrolysis is inaccurate. Thus, the 
walker motifs are not involved in complex formation (Chen et al., 2008). 
The large coiled –coil structure in the central region can fold back and allows both Walker mo-
tifs to interact directly. This interaction forms a globular ABC transporter-type ATPase domain. 
The Mre11 subunit binds to the coiled-coil region near the ATPase domain and it was shown 
that the ATPase activity of Rad50 is required to form the complex with Mre11. Rad50 molecules 
can dimerize through the “hinge” region at the end of the coiled-coil arm. This arm contains a 
zinc hook with the Cys-X-X-Cys (CXXC) motif; this architectural structure suggests that two 
Rad50 form a metal-mediated bridging complex between two DNA-binding heads. The dimeri-
zation is shown in the presence of Zn2+, the MR complex can build a lot of different complexes 
and shapes that are important for the different cellular functions of the complex. If the conserved 
cysteine is mutated it leads to a higher sensitivity to ionizing radiation (Hopfner et al., 2002). 
The length and conformation also suggest the role to link sister chromatids in homologous re-
combination and DNA ends in non-homologous end joining. But the dimerization of the Rad50 
hook domain is not necessary for DNA binding (Cahill and Carney, 2007). 
Like other ABC transporter superfamily members, Rad50 has the activity to reversible transfer a 
phosphate group from ATP to AMP to generate two ADPs. The ATPase and adenylate kinase 
activities act competitively and may be regulate conformational changes required for the activity 
of Rad50. The adenylate kinase activity is required for DNA tethering. 
Rad50 can enhance the nuclease activity of Mre11, while ATP shows no effect and also the exo-
nuclease activity of Mre11 is not affected (Chen et al., 2008). It was also shown that Rad50 itself 
has no nuclease activity, so that the increased nuclease activity in the MR complex does not 
come from the Rad50 protein itself. Mre11 binds next to the Walker A and Walker B motifs in 
the coiled-coil region of Rad50 (Hopfner et al., 2002; Paull and Gellert, 1998). The MR complex 
works in an ATP-dependent manner in DNA end processing in meiosis and mitotic DSB repair. 
Through conformational changes in Rad50, the DNA substrate is prepared for cleavage by 
Mre11, and afterwards the DNA is released upon ATP hydrolysis along with the reversal of the 
Rad50 conformation (Hopfner et al., 2002). (Figure 4) 
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Figure 4: Structure of Rad50. 
(Reproduced from Rupnik, Chromosoma, 2010)  
Domain structure of Rad50. Indicated with stars are known mutation in Rad50 (a). Schematic dimerization of Rad50 
(b). 
 
2.3.3. Nbs1 
Nbs1 is thought to regulate the MR functions, it is required for the nuclear localisation of Mre11 
and Rad50, and it is also needed for the rapid focal assembly of the MRN complex to the sites of 
DNA damage. It stimulates the activities of Rad50 and Mre11 such as nuclease activity and 
ATP-dependent DNA unwinding (Rupnik et al., 2010). 
The protein was found mutated in patients with the Nijmegen breakage syndrome (NBS), which 
is an autosomal recessive disorder that leads to sensitive to irradiation, chromosome fragility and 
fails to activate cell cycle checkpoints in response to DNA damage. In the patient’s cells no 
MRN nuclear foci are formed following the induction of DSB by ionizing radiation, because in 
most NBS patients, only a truncated form of NBS1 (called p70) is expressed, that cannot bind to 
MDC1 (Carney et al., 1998). 
Nbs1 has an important role in the modulation of ATM activation in the irradiation induced sig-
nalling cascade, through interaction with Mre11, it modulate the timing and the amplitude of 
ATM activation in response to low doses of IR (Horejsi et al., 2004). In NBS patients the phos-
phorylation of Chk2, Smc1 and Fancd2 by ATM is reduced or absent. Through multiple contacts 
with MRN a conformational change in ATM is induced, which increases its affinity for its sub-
strates (Lee and Paull, 2004). 
Nbs1 also modulates the DNA binding activity and specificity of Rad50. Nucleotide-dependent 
DNA binding is strongly promoted when Nbs1 is present, this increased DNA binding activity 
may explain the requirement for Nbs1 in DNA unwinding (Lee et al., 2003). 
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Depending on the stoichiometry of Mre11 and Nbs1, different MRN sub-complexes are formed. 
Rad50 can be present as monomer, dimer or multimer in complex with Mre11 and Nbs1. If Nbs1 
is in abundance compared to Mre11, a complex containing Rad50 multimers is preferably 
formed while equal amounts seems to lead to the formation of Rad50 monomers (van der Linden 
et al., 2009). These different forms are one explanation why this complex has a lot of different 
functions and that the stoichiometry of MRN is important to consider in structural studies. (Fig-
ure 5) 
 
 
 
 
Figure 5: Structure of Nbs1 
(Reproduced from Rupnik, Chromosoma, 2010)  
Domain structure of Nbs1, indicated with stars are mutations found to cause Nijmegen Breakage Syndrome (NBS) 
(a). Three dimensional structure of Nbs1 (b) 
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2.4. The Baculovirus expression system 
In the baculovirus expression system insect cells or larvae are used to produce heterologous pro-
tein. The strong polyhedrin promoter of the Autographa californica nuclear polyhedrosis virus 
(AcNPV) is often highly expressed during the late stages of infection. Heterologous proteins 
produced in the insect cells are mostly functional like their endogenous counterparts, since they 
are processed, modified and targeted to their appropriate cellular location. In contrast to other 
expression systems (especially prokaryotic expression systems) the baculovirus expression sys-
tem has several benefits. For intracellular proteins high levels of heterologous gene expression is 
achieved, while the proteins are soluble and easily recovered. Hetero-oligomeric protein com-
plex expression can be achieved by simultaneous infection with several viruses or by infection 
with a single virus that contains several expression cassettes. The baculoviruses have a very lim-
ited host range, what makes them safe to work with. The genome contains all genetic infor-
mation needed for propagation and helper cell lines or helper viruses are not needed. 
 
Due to the large circular double-stranded DNA genome with multiple recognition sites for re-
striction endonucleases, the recombinant baculovirus are constructed in two steps. First, the de-
sired cDNA is cloned into a plasmid transfer vector downstream from a baculovirus promoter 
flanked by baculovirus DNA derived from nonessential loci. The heterologous expression cas-
sette is inserted into the genome of the parent virus by homologous recombination in vivo in the 
insect cells. Alternatively, specifically engineered bacteria (E.coli) can be used for the recombi-
nation step. In this case, recombination-proficient E.coli containing the entire baculovirus ge-
nome are transformed with the transfer vector and the modified full length baculovirus genome 
is subsequently isolated from the bacteria. This can then directly be used to transfect insect cells. 
In this study, only the latter system was used. (Figure 6) 
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2.5. Electron microscopy 
Single-particle electron microscopy (EM) is a good way to investigate the structure of the large 
complexes of the DNA repair machinery. These molecules are often dynamic and their confor-
mation is related to their function. X-ray crystallography on its own is not able to analyse these 
complicated structures. In the 3D reconstruction, known X-ray structures can be fitted into the 
shape of the complexes in order to get a better knowledge about were specific structural ele-
ments or domains are located. But the purification of DNA repair complexes is often difficult 
because they are heterogeneous in their subunit content, they can have low stability and some-
times interact only with specific DNA molecules. Protein complexes can be analysed as a whole, 
but this makes it impossible to identify and map the regions were the proteins interact, therefore 
it is better to start with the analyses of the single protein (Llorca, 2007). 
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3. Materials and Methods 
3.1. Materials 
3.1.1. Antibodies 
3.1.1.1.  Primary antibodies 
Polyclonal sheep α-Mre11 D151 (1:5000) 
Polyclonal sheep α-Rad50 D149 (1:5000) 
Monoclonal mouse α-alpha-tubulin clone DM1A (1:10000)  Sigma® 
3.1.1.2.  Secondary antibodies 
Polyclonal ECL α-mouse HRP-linked sheep antibody (1:5000) GE Healthcare 
Donkey anti-goat IgG-HRP (1:5000)        Santa Cruz Biotechnology 
3.1.2. Antibiotics 
Ampicillin (100mg/ml in dH2O)  Fluka® Chemie AG 
Penicillin-Streptomycin (10'000 units/ml)  Invitrogen® 
Kanamycin   Sigma® 
Gentamicin  Sigma® 
Tetracyclin   Sigma® 
3.1.3. Bacteria strains 
E.coli XL1 blue 
E.coli DH10Bac 
3.1.4. Chemical reagents 
Acetic acid   Sigma-Aldrich 
Acrylamid-bis 40%  Serva® 
Agarose   Promega 
Bacto Tryptone  BD 
Bacto yeast extract  BD 
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Betamercapto Ethanol  Fluka® 
Bromphenol blue sodium  Sigma® 
Buffer 2 for restriction enzymes  New England Biolab 
Buffer 4 for restriction enzymes  New England Biolab 
Cellfectin   Invitrogen 
Coomassie Briliant Blue R250  Fluka® 
DMSO   Sigma® 
ECL (two solutions, mixed 1:1)  GE Healthcare® 
EDTA    Fluka® 
Ethanol   Merck® 
Fetal calf serum (FCS)  Gibco 
Glucose   Fluka® 
Glycerol   Fluka® 
Glycin    Biosolve 
Grace's Insect Medium  Invitrogen® 
HEPES   Fluka® 
Hydrochloride acid (HCl)  Merck® 
IPTG    Merck® 
Isopropanol  Sigma® 
KCl    Fluka® 
KH2PO4   Merck® 
KOH    Merck® 
Methanol   Merck® 
Magnesium chlodride (MnCl2)  Merck® 
Nonidet P40  Fluka® 
Ponceau S   Sigma® 
Sodiumdodecylesulfat (SDS)  Fluka® 
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Sodium chloride (NaCl)  Fluka® 
Sodium Hydrogenphosphate (Na2HPO4) 
Streptavidin, immobilized on Agarose  Fluka® 
T4 DNA Ligase Buffer  Fermentas 
Tris 1M   Biosolve 
Tween 20   Fluka® 
X-gal 
3.1.5. Enzymes 
BamHI   New England Biolabs® 
CIP    New England Biolabs® 
EcoRI    New England Biolabs® 
EcoRV   New England Biolabs® 
Expand High Fidelity Enzyme (100U/μl) Mix Roche® 
HindIII   New England Biolabs® 
KpnI    New England Biolabs® 
SalI    New England Biolabs® 
T4-DNA-Ligase  Fermentas® 
XbaI    New England Biolabs® 
XhoI    New England Biolabs® 
3.1.6. Insect cell lines 
SF21 
3.1.7. Vectors 
pSG5-Nbs1 (S118A)   Constructed by Lucijana Pavic  
pEXPR-IBA103   IBA (BioTAGnology) 
pFastBac-Nbs1-Mre11-Strep    Constructed by Lucijana Pavic 
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3.2. Methods 
3.2.1. DNA manipulation 
3.2.1.1. Agarose gel electrophoresis 
Separation of digested plasmid DNA or PCR products on a 1% agarose gel and visualized the 
ethidium bromide staining under a UV light source. 
 
Buffers and Medias: 
1x TAE buffer 
6x loading buffer 
1kb Marker 
 
Chemical Reagents: 
Agarose 
Ethidium bromide solution 
 
Electrophoresis Kit: 
Mini Sub DNA Cell   Bio-Rad® electrophoresis system 
Power Pac 200 (at 80V)   Bio-Rad® power supplies 
ChemiImager 5500   Alpha Innotech® 
 
Gel preparations: 
100ml 1x TAE buffer 
1g Agarose 
4µl Ethidium bromide solution 
 
3.2.1.2.  DNA-Digestion 
DNA was digested for at least 2 hours at 37°C 
 
Preparations: 
15.5µl  H2O 
5µl  DNA (1µg/µl) 
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2.5µl  Buffer for Restriction enzyme (1-4) 
1µl  Restriction enzyme 1 
1µl  Restriction enzyme 2 
 
To avoid self-ligation of the empty vector CIP was added for 1 hour at 37°C. 
 
1µl  CIP     New England Biolabs 
 
3.2.1.3.  NucleoSpin® Gel-extraction and PCR clean-up 
The gel extraction and PCR clean-up was done according the Macherey-Nagel protocol (proto-
col at a glance, rev. 03) for NucleoSpin® Extract II by using mini spin columns with silica 
membrane technology. 
 
Buffers and Medias: 
NT binding buffer     Macherey-Nagel® 
NT3 wash buffer     Macherey-Nagel® 
NE elution buffer     Macherey-Nagel® 
 
Material: 
NucleoSpin® mini spin columns 
 
3.2.1.4.  Ligation arrangements 
The digested DNA fragments were ligated by T4 DNA ligase in a 15°C warm water bath over-
night. 
 
Preparations: 
1µl T4 DNA Ligase    Fermentas® 
1µl T4 Ligase Buffer    Fermentas® 
3µl Insert 
5µl Vector 
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3.2.1.5.  Mini plasmid preparation (Mini Prep) 
The recombinant plasmid DNA was quantified and analysed according to the following protocol: 
From an overnight bacteria culture the cell pellet was collected by centrifugation (4000rpm for 
10min at 4°C) and dissolved in 250µl S1 buffer. To lysate the cells 250µl S2 buffer was added 
and mixed gently. The protein was precipitated with 350µl S3 buffer. The mix was centrifuged 
at 14000rpm for 15min at 4°C. The supernatant was transferred to a new tube and mixed with 
560µl isopropanol, this was centrifuged at 14000rpm for at least 30min at 4°C, the supernatant 
was discarded, 500µl ethanol were added and again centrifuged at 14000rpm for 10min. The su-
pernatant was discarded and the pellet was air-dried for 2h, afterwards it was dissolved in 25µl 
dH2O. 
 
Buffers: 
S1 Resuspension buffer      Macherey-Nagel® 
S2 Lysis buffer      Macherey-Nagel® 
S3 Elution buffer      Macherey-Nagel® 
 
3.2.1.6.  Expand high fidelity PCR System 
The Expand High Fidelity PCR Kit (Roche®) includes the following contents: 
• Expand High Fidelity Enzyme Mix* 
• Expand High Fidelity buffer (10x) with 15mN MgCl2 
• Expand High Fidelity buffer (10x) without MgCl2 
• MgCl2 25mM Stock Solution 
* Enzyme storage buffer: 20mM Tris-HCl, pH7.5 (25°C); 100mM KCl; 1mM Dithiothritol 
(DTT); 0.1mM EDTA; 0.5% Nonidet P40 (v/v); 0.5% Tween 20 (v/v); 50% glycerol 
Additional Material: 
• dNTP-Mix (deoxyribonucleosidtriphosphat mix) 
• 0.2ml thin-walled PCR tubes (Axygen PCR 02-C) 
• Thermal block cycler (Applied Biosystems GeneAmp® PCR System 2700) 
The PCR reaction mix was prepared according the Expand High Fidelity PCR System protocol: 
Volume Reagent        Final Concentration 
4.125µl dH2O 
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2.5µl  10x Expand High Fidelity buffer (without MgCl2) 
5µl  MgCl2 (25mM) 
2µl  dNTP-Mix        200µM 
1µl  dsDNA template        1-10ng 
5µl  Forward primer        300nM 
5µl  Reverse primer        300nM 
0375µl  Expand High Fidelity enzyme mix       1.7U/reaction 
The MgCl2 amount was changed to 1, 2.5, 5µl to find the best PCR activity. 
Thermal cycling: 
 Cycles Temperature Time 
Initial Denaturation 1x 94°C 5min 
Denaturation  94°C 2min 
Annealing 25x 55°C 30s 
Elongation  72°C 2min 
Final Elongation 1x 72°C 7min 
Cooling  4°C ∞ 
 
3.2.1.7.  Transformation of chemically competent E.coli cells with plasmid DNA 
Transformation is a method to get plasmid DNA into a competent bacteria cell. 
Thaw an aliquot competent XL1blue E.coli cells on ice. Pipette 2-5µl Plasmid DNA in a cooled 
Eppendorf, add 50µl cell suspension, tap it gently and incubate for at least 15min on ice. Heat 
shock the suspension 40sec at 42°C on the heating block and afterwards cool it for 1min on ice. 
Add 400µl liquid LB medium and culture the cells at 37°C for 30min in the shaking incubator. 
The cell suspension was centrifuged 2min at 14000rpm and the supernatant was discarded until 
50µl were left, in this the pellet was dissolved and then spread on agar plates by small sterile 
glass beads. The plates were incubated overnight at 37°C. 
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Buffers and Medias: 
LB-Medium 
 
Bacteria cells: 
E.coli XL1blue were present in the Stucki lab 
 
3.2.1.8. Transposition 
In the transposition the recombinant pFastBac donor plasmid is transformed into DH10Bac for 
the transposition into the bacmid. 
First Luria Agar plates containing 50μg/ml kanamycin, 7μg/ml gentamicin, 10μg/ml tetracy-
cline, 100μg/ml X-gal and 40μg/ml IPTG are made. DH10Bac competent cells are thawed on 
ice, 100μl of them are pipet in a round-bottom polypropylene tube and then 5μl recombinant do-
nor plasmid is added. Incubated 30min on ice then heat shock at 42°C for 45sec, immediately 
chill the mixture on ice for 2min. Afterwards add 900μl S.O.C. medium and place it in a shaking 
incubator at 37°C for 4h. Serial dilute the cells with S.O.C. media and spread 100μl of each dilu-
tion on the plates. Incubate them for 24 till 48 hours. White colonies are then further grown in 
liquid media containing the antibiotics and analysed in a minipreparation. 
 
Antibiotics 
Kanamycin  Sigma® 
Gentamicin Sigma® 
Tetracycline Sigma® 
 
Chemicals 
X-gal 
IPTG 
 
3.2.2. Protein manipulation 
3.2.2.1.  Determination of protein concentrations by Bradford 
To determine protein concentrations of NP40 cell extracts the Bradford analysis was used. First 
the absorbance (595nm) of four BSA standard solutions was measured to calculate a standard 
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curve of absorbance. The resulting curve was used to determine the protein concentration of the 
samples. 
 
Protocol: 
Dilute Bio-Rad Protein-Assay Solution 1:5 in water. Prepare the samples as follows: 
Standard: 20µl Standard solution + 1ml diluted Bradford solution 
Blank:  20µl H2O + 1ml diluted Bradford solution 
Sample: 20µl H2O + 2µl Lysate + 1ml diluted Bradford solution 
Add Bradford solution at the end and mix it to avoid precipitation after time. Measure the ad-
sorption at 595nm the results should be between 0.1 – 1.0. 
 
Material: 
Cuvettes (halb-mikro)     Greiner Bio One 
Genesis 10UV scanning     Digitana AB thermo spectronic systems 
Albumin from bovine Serum, Biochemika Fraction V Fluka Chemie AG 
 
3.2.2.2.  SDS-PAGE (SDS-polyacrylamide gel electrophoresis) 
By applying an electric field through the SDS-PAGE gel proteins are separated according their 
molecular weight. 
 
Buffers: 
2x SDS loading buffer 
1x Stacking-Gel buffer 
2x Running-Gel buffer 
1x Running-Buffer 
Stain 
Destain 
 
Electrophoresis Kit: 
Mini-Protean Tetra Electrophoresis System  Bio Rad® vertical electrophoresis system 
Power Pac 200 (15min 80V, than 150V)  Bio Rad® power supplies 
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Gel preparation: 
 6% 8% 10% 12% 15% Stacking gel 
2x Gel buffer 2.5ml 3ml 3ml 5ml 5ml 5ml 2.4ml 
40% Acrylamid-bis (w/v) 0.75ml 1.2ml 1.5ml 2.5ml 3ml 3.75ml 0.375ml 
dH2O 1.75ml 1.8ml 1.5ml 2.5ml 4ml - - 
APS 10% 50μl 60μl 100μl 100μl 100μl 100μl 30μl 
TEMED 10μl 10μl 10μl 15μl 15μl 15μl 8μl 
 
3.2.2.3.  NP40 extract 
With the NP40 soluble proteins can be extracted out of the cells, and in comparison to SDS Ex-
tract the proteins are not denatured and interactions between proteins can still be analysed. 
The cells were centrifuged for 1 minute at 1500rpm, then washed with PBS, afterwards they 
were resuspended in 150μl Extraction buffer A and incubated 10min on ice. Then they are cen-
trifuged at 20000g for 10min. The suspension was used for further experiments. 
 
Buffers: 
Extractionbuffer A 
PBS 
 
3.2.2.4.  Western blot analysis 
Western Blot is a technique to transfer proteins form a SDS-Gel to a nitrocellulose membrane. 
The proteins can then be detected with antibodies. 
The gel-membrane sandwich is prepared first with the gel located towards the black side. The 
blot is run in transfer buffer over night at 30V. The membrane is washed with dH2O and after-
wards stained with Ponceau S for about 10min. The part of interest is cut out and destained with 
TBS-T. Then it is blocked with 5% milk powder in TBS-T for 1h. The primary antibody is dilut-
ed in 2.5% milk-TBS-T (1:1000 or 1:5000) and incubated at room temperature for 4h. Next the 
membrane is washed 3x5min with TBS-T, afterwards the secondary antibody is added, which is 
diluted 1:5000 in TBS-T 2.5% milk, the membrane is incubated at RT for 1h. Then again the 
membrane is washed 3x with TBS-T, followed by drying and adding of the ECL-mix for 1min. 
The membrane is wrapped in a plastic film, put in an x-ray cartridge. An x-ray film is exposed 
and developed. 
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Material: 
Mini Trans-Blot cell Bio-Rad blotting systems 
Power Pac 200 Bio-Rad power supplies 
Nitrocellulose membrane GE Water & Process Technologies 
Typon optimax Raymed Imaging AG 
Contatyp medical X-ray film Typon Holding AG 
 
Buffers and Medias: 
ECL (two solutions, mixed 1:1) Amersham Biosciences 
TBST 
5% TBST-milk 
Transfer buffer 
 
3.2.2.5.  Coomassie-blue staining 
Coomassie-blue staining is used to stain proteins on an SDS-Page. 
The staining was done accordingly to the student course protocol TIG 15: 
The gel is stained and fixed in Coomassie Brilliant Blue Staining solution about 15min. After-
wards it is rinsed with water two times and developed in destain solution. 
 
Materials: 
Staining-Box 
 
Solutions: 
Stain 
Destain 
 
3.2.2.6. ProBond resin purification 
The ProBond Resin beads are used for pull downs of His-tagged protein. 
Take an appropriate amount of beads and resuspend them three times in Buffer 1. Add the 
NP40-Extract to the beads, hold an aliquot of the extract back for further analysis, incubate the 
mix 30min at 4°C while rotating. After 30min take a small aliquot of the supernatant, then wash 
the rest 3 times with Buffer 1. Dissolve the beads in 500µl Buffer 2 to elute the bound protein 
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and incubate it 10min at 4°C under motion. Store an aliquot of the eluate. Continue with analyse 
or further purification. 
 
Material 
ProBond Resin  Invitrogen 
 
 
Buffer 
Buffer 1 
Buffer 2 
 
3.2.2.7. FPLC purification 
The first step of the purification was performed according to the manual on the ÄktaFPLC Sys-
tem. A HisTrapTM HP Column was used to trap the His-tagged Rad50. The Elution was done 
over a 10ml graph from Buffer A to Buffer B. 
 
Material 
ÄktaFPLC System  Amersham Pharmacia Biotech 
HisTrapTM HP Columns  GE Healthcare 
 
Buffers 
Lysisbuffer 
Buffer A 
Buffer B 
 
3.2.2.8. Dialysis 
Dialysis is a process to separate molecules in solution by the difference in their rates of diffusion 
trough a diaphragm. The Dialysis was performed according to the following protocol: 
The Dialysis Cassette is hydrated in the dialysis buffer for two minutes. Afterwards the sample is 
added and then incubated about 30 Minutes, the buffer is changed and again incubated for 30 
Minutes. Then the buffer is again changed and the cassette is incubated over night at 4°C. 
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Material 
Slide-A-Lyzer® Dialysis Cassettes Thermo Scientific 
 
3.2.2.9. Streptavidin purification 
With the Streptavidin immobilized on Agarose Strep-tagged protein can be purified out of a 
sample. 
First the Streptavidin beads are equilibrated in Buffer C. Then the sample is added and incubated 
for one hour at 4°C. The beads are washed three times with Buffer D and afterwards the proteins 
are eluted with biotin. The different fractions are analysed with SDS-Gel. 
 
Material 
Streptavidin, immobilized on Agarose CL-4B  Fluka® 
Biotin 
 
Buffers 
Buffer C 
Buffer D 
 
3.2.2.10. Dynabeads purification 
With the Dynabeads the Strep-tagged proteins are pulled out. 
First the beads are equilibrated in Buffer C Then the sample is added and incubated for one hour 
at 4°C. The beads are washed three times with Buffer D and afterwards the proteins are eluted 
with biotin. The different fractions are analysed with SDS-Gel. 
 
Material 
Dynabeads with Streptavidin  Invitrogen 
Biotin 
 
Buffers 
Buffer C 
Buffer D 
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3.2.3. Manipulations with bacterial and insect cell lines 
3.2.3.1.  Preparation of chemically competent E.coli cells 
E.coli cells were converted into chemically competent cells to achieve better transformation effi-
ciency according to the following protocol: 
All the tubes and solutions were chilled and it is recommended to work in the cold room. 1ml 
XL1blue E.coli strain was incubated in 200ml S.O.C. medium at room temperature overnight. 
The cells were grown to an OD600 as close to 0.45 as possible, the cultures were split into sterile 
falcon tubes and place on ice for 10min, then they were centrifuged 15min at 3500rpm at 4°C, 
the supernatant was carefully discard. The pellet was resuspended in 64ml HTB and placed on 
ice for 10min. After centrifugation at 3500rpm for 15min at 4°C, the supernatant was carefully 
discard and the pellet resuspended in 16ml. Afterwards 1.2ml filter sterilized DMSO was added 
slowly. Then the suspension was aliquoted in pre-cooled Eppendorf tubes (200µl per tube) and 
shock-frozen in liquid nitrogen. The aliquot is stored at -80°C. 
 
Material: 
Cuvettes (halb-mikro)     Greiner Bio One 
Genesis 10UV scanning     Digitana AB thermo spectronic systems 
Sorvall RC 3C Plus     Sorvall centrifuges 
Sorvall HRL6     Sorvall rotors 
Nalagene 1000ml tubes 
 
Buffers and Medias: 
S.O.B. Medium 
S.O.C. Medium 
HTB buffer 
 
Chemical Reagents: 
DMSO 
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3.2.3.2.  Transfection 
Transfection is a method to bring foreign DNA into cells of higher eukaryotes. 
The instruction manual Bac-to-Bac® Baculovirus Expression Systems from Invitrogen was 
used. Seed 9x105 cells per well in 2ml media containing Penicillin/Streptomycin and FCS. Let 
the cells attach for about 1h. Prepare Solution A containing 5μl of min-prep bacmid DNA in 
100μl media without antibiotics and Solution B containing 6μl CellFECTIN in 100μl media 
without antibiotics. The two solutions are mixed and incubated for about 30min. Wash the cells 
with media without antibiotics. Then add 0.8ml media to the mixed solutions and overlay the 
cells. Incubate it for 5h at 27°C. Remove the transfection mix, add 2ml media with antibiotics 
and incubate it for 72h at 27°C. 
 
Buffers and Medias 
Graces Insect Media w/o Penicillin/Streptomycin + FCS 
CellFECTIN 
 
Cell lines 
SF21 
 
Materials 
6-well plate 
27°C Incubator 
 
3.2.3.3.  Virus titration 
Virus titration is a method to determine the efficiency of the produced virus. The titration was 
done according to the following protocol: 
The cells were scratched off the plate and filled in a tube. With the “Neubauer counting cham-
ber” the amount of cells per Millilitre was determine. If necessary the volume was adjusted to 
20x105 cells per 2ml media, this was then seeded on a 6-well plate and incubated at 27°C for 1h. 
Afterwards the media was aspirated and 500μl new media was added. The virus was added in 
different amounts and the plate was again incubated at 27°C for 1h. After one hour 1.5ml media 
was added and the plate incubated 2-3 days at 27°C. At the end of the incubation the infected 
cells can be processed further. 
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Buffers and Medias 
Graces Insect Media w/o Penicillin/Streptomycin + FCS 
 
Cell lines 
SF21 
 
Virus 
Baculovirus with Mre11 cDNA 
Baculovirus with Rad50 cDNA 
 
Material 
6-well plate 
27°C incubator 
 
3.2.3.4.  Virus amplification 
Virus amplification is a technique to amplify the virus stock. 
The cells were plated out, infected with the reproductive virus, incubated for two days and har-
vested. The remaining cells were centrifuged and the supernatant transferred to a new tube. 
 
Buffers and Medias 
Graces Insect Media with Penicillin/Streptomycin + FCS 
 
Cell line 
SF21 
 
Virus 
Baculovirus Mre11 
 
Material 
100mm plates 
Falcontubes 
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4. Goals of the thesis 
4.1. Expression and purification of differentially tagged Mre11/Rad50 het-
erodimer from baculovirus-infected insect cells 
Based on preliminary results using electron microscopy (EM) to monitor structural changes in 
the MRN complex upon binding to MDC1 our group started a collaboration with Prof. Oscar 
Llorca in Spain. Oscar Llorca is an expert in structure determination of large multi-subunit DNA 
repair complexes by EM reconstruction. Previously, the former technical assistant Lucijana 
Pavic purified MRN and MR subcomplexes from Baculovirus infected insect cells and these pu-
rified proteins were sent to Spain for analysis. The data revealed that the MR heterodimers were 
present as monomers, multimers and protein aggregates. Since both Rad50 and Mre11 were 
tagged with a His6-affinity tag, it was not possible to separate monomeric proteins and protein 
aggregates from heterodimeric Mre11/Rad50 complexes. Therefore, in order to overcome this 
problem, the aim of this project was first to generate Streptavidine-binding peptide (Strep)-
tagged Mre11. This could then be co-expressed with His-tagged Rad50 in Baculovirus-infected 
insect cells. Subsequently, tandem purification over Nickel-NTA columns and Streptavidin 
beads could be used to purify the MR dimers. 
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5. Results 
5.1. Tandem purification of Mre11/Rad50-dimers using the Baculovirus ex-
pression system  
5.1.1. Virus production 
Preliminary data from our lab showed that Mre11 and Rad50 when co-purified over a His-
affinity column were present in monomers, dimers and aggregates. To isolate pure dimers of 
Mre11 and Rad50, we sought to exchange the Mre11-tag from His to Strep, while the Rad50 
His-tag was left unaltered. Since our former technician L. Pavic had already constructed a bac-
mid containing the Strep-tagged full-length Mre11 cDNA, this construct was used directly for 
recombinant virus production. The bacmid DNA, containing the sequence of Mre11-Strep, was 
first transfected into SF21 insect cells to produce the Baculovirus. The transfection led to six dif-
ferent virus stocks (1A-1C, 2A-2C). These viruses were then tested for their Mre11 expression 
capacity through an infection of the SF21 cells. The cells were collected 3 days post infection 
and the proteins were extracted with a NP-40 extraction buffer and loaded on a SDS-Gel, Brad-
ford protein concentration test was used to load equal amounts of total protein in each lane. 
Mre11 expression was analysed by western blotting, using a sheep anti human Mre11 polyclonal 
antiserum. All six virus stocks showed a similar expression of Mre11. Some degradation prod-
ucts could be seen on the blot (lower bands in Figure 7), probably because no protease inhibitors 
were used in this extract. 
 
 
Figure 7: Mre11 is expressed in all produced virus stocks. α-Mre11-Ab. Exposure: 10 sec. 
 
Next, a titration of one Mre11 virus stock (1A) was performed to test the best concentration of 
virus for the expression. In parallel, the Rad50 virus produced by L. Pavic was also titrated in the 
same way. The extraction was again done with NP-40 extraction buffer. While the Rad50 virus 
showed a high titer (Figure 8), the Mre11 virus concentration was low (Figure 9) and thus, it was 
decided to amplify it. For the amplification, SF21 cells were infected with recombinant Mre11 
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baculovirus and the supernatant was harvested after 48 hours. The thus amplified Mre11 virus 
was again titrated and this time, showed a far higher titer (Figure 10). 
 
 
Figure 8: Rad50 titration. x µl were used for cell infection. As positive control an U2OS cell extract was used. α-
Tubulin was used as loading control. Exposure: 30 sec. 
 
 
Figure 9: First Mre11 titration. x µl virus were used for cell infection. As positive control an U2OS cell extract was 
used. α-Tubulin was used as loading control. Exposure: 30 sec. 
 
 
Figure 10: Second Mre11 titration after amplification. x µl virus were used for cell infection. α-Tubulin was used as 
loading control. Exposure: 30 sec. 
 
5.1.2. Protein purification 
With these results we decided to perform a pilot expression in order to test the binding efficiency 
of the MR complexes to the Nickel-NTA resin and the Streptavidin beads, respectively. SF21 
cells were co-infected with the same amount of Mre11 and Rad50 Baculovirus. The NP-40 cell 
extract was then incubated with Nickel-NTA resin. The resin was washed 3 times with Buffer 1 
and the bound proteins were eluted with 500µl Buffer 2. Subsequently, the eluted fraction was 
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dialyzed and incubated with the second affinity matrix (Streptavidin immobilized on agarose). 
The Streptavidin beads were washed and bound protein was eluted with SDS loading buffer. The 
different samples were then analysed by SDS-PAGE and Coomassie blue staining or Western 
blotting. The results revealed that some of the protein could bind to the first Nickel-NTA resin 
(see Figure 11, lane EL1). However, a lot of protein was found in the flow through, which basi-
cally indicates that most of the protein did not bind efficiently to the affinity beads. In the second 
purification step, no proteins were found in the elution, but everything was found in the superna-
tant (see Figure 11, lane SN2 and EL2), indicating that no MR heterodimeric complexes bound 
to the Streptavidin beads. 
 
 
Figure 11: Test expression and purification. NP-40 Extract (Ex) was purified over ProBond Resin beads, after in-
cubation a supernatant probe (SN1) was taken to see the binding efficiency. After 3 wash steps the protein was elut-
ed (EL1), this eluat was used to purify over Streptavidin beads. Again the supernatant (SN2) was taken after incuba-
tion. The beads were then eluted (EL2), which showed that the whole protein was lost and found in the supernatant. 
Exposure time: 30 sec. 
 
After the pilot expression a larger number of plates were co-infected with recombinant Mre11 
and Rad50 baculoviruses. The extraction procedure was adjusted to the conditions that are re-
quired for the ÄktaFPLC, so Triton 100 was used instead of NP-40. A HisTrapTMHP Column 
was used to capture the His-tagged Rad50 monomers, as well as the MR dimers. The proteins 
were then eluted with a 10 ml linear gradient of Imidazole (20 mM – 200 mM) and the purified 
protein factions were analysed by SDS-PAGE (Coomassie staining) and by Western blotting us-
ing sheep anti human Rad50 and Mre11 polyclonal antisera, respectively. The results revealed 
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that only very little protein bound and eluted from the column. Nevertheless, the purification was 
continued. 
 
 
Figure 12: ÄktaFPLC elution graph. UV 280nm: blue line and UV 254nm: red line rise when the protein is eluted. 
Increasing concentration of Imidazole buffer: green line. 
 
Figure 13: Fractions after ÄktaFPLC purification of SF21 cell extract over His-trap column. From the Lysate too 
little was loaded to see the Rad50 and Mre11 bands. The binding capacity of the column seems to be good since nei-
ther Mre11 nor Rad50 can be detected on the Coomassie. Marker (M), pellet (P), lysate (L), flow through (F), wash 
(W) 
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Figure 14: Eluted fractions after ÄktaFPLC purification of SF21 cell extract over His-trap column. The Rad50 con-
centration increases from fraction A6 on to A9 and decreases again. Mre11 shows a similar behaviour. Marker (M), 
Fractions (A3-A11).  
 
 
Figure 15: Western blot analysis of the ÄktaFPLC purification of SF21 cell extract over His-trap column. From the 
Lysate too little was loaded to detect the protein. In the flow through a part of the Rad50 was lost. Rad50 shows a 
slight accumulation in the fractions A7 – A9, afterwards the concentrations decreases. Mre11 is pulled down with 
the latter fraction A9 –A11. Marker (M), Lysate (Lys), Flow through (Flow), Wash (Wash), Fractions (A7 –A11). 
Exposure time: 30sec. 
 
The fractions A7 – A9 were pooled for the next purification step. This pool was then dialysed 
with a dialysis cassette against buffer d to remove the Imidazole and to adjust the salt concentra-
tion for the next purification step. First, we tried to purify the dialysate over Streptavidin immo-
bilized on agarose. But the SDS-PAGE analysis and a Western blotting revealed that neither in 
the elution nor on the beads Mre11 and Rad50 protein was detectable, only in the flow through 
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fraction the proteins appeared. (Figure 16, lane “Flow”) Since Streptavidin-coated Dynabeads 
were available in the laboratory, the supernatant was tested if the protein would bind to these 
beads. But again the protein did not bind to the beads and was found completely in the flow 
through (data not shown). 
 
 
Figure 16: Western Blot of Strep tag purification over Streptavidin, immobilized on agarose. The proteins were lost 
in the Flow through; this indicates that the protein could not bind to the beads. Marker (M), lysate (L), flow through 
(Flow), washing steps (W1 –W3), elate (E1 – E3). Exposure time: 1 min 
 
Why did the recombinant Mre11 and Rad50 proteins not bind to the beads? First, the protein ex-
pression level could have been insufficient and thus, the protein concentration too low to bind ef-
ficiently to the beads. Alternatively, it was also possible that the sequence of the Strep tag was 
not correct, which would also interfere with protein binding to the Streptavidin beads.  
To test these two possibilities, the protein expression was repeated and at the same time, the 
Mre11-Strep transfer vector was sent for sequencing. For this second large-scale expression a 
larger number of plates were co-infected with Mre11 and Rad50 recombinant Baculoviruses. 
The extraction was done in the same way as before. The first purification step was again carried 
out over the ÄktaFPLC system with a HisTrapTMHP column. The first elution didn’t seem to 
work because no protein could be detected in the elution fractions, neither by UV absorption nor 
by the Bradford protein concentration assay. It was discovered that one tube of the B-pump of 
the Äkta system was loose. After repairing, the elution was repeated with a gradient of Imidazole 
and proteins in the elution fractions were detected. Nevertheless, the UV absorbance curve of the 
Äkta system looked odd (Figure 17), which could later be explained by a defective UV-lamp that 
was detected upon maintenance of the Äkta-FPLC system. The fractions with the highest protein 
concentration (according to the Bradford assay) were analysed by SDS-PAGE and Western blot-
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ting. This time SDS-PAGE (Coomassie blue stain) results showed a better purification efficiency 
than in the previous run and the best three fractions were pooled for dialysis (Figure 18 and 19). 
Unfortunately, at the same time the sequence report from Microsynth revealed that the Mre11-
Strep construct was faulty. The expression cassette contained only a short tag with a STOP co-
don instead of a full length Strep-tag, which would explain why the recombinant Mre11 proteins 
would not bind to the Streptavidin beads. Because of this result, the protein production was 
stopped. 
 
Figure 17: Second Elution with the ÄktaFPLC of SF21 cell extract over a His-trap column. The first part of the UV 
280nm spectrum looks different because there the ÄktaFPLC was adjusted to start again with the purification. 
While the fractions were eluted the UV 280nm spectrum was rising but no peak like normal appeared. UV 280nm 
(Blue line), Concentration of Imidazole Buffer (Green line). 
 
 
Figure 18: Fraction analyses after ÄktaFPLC purification with His-trap column. Almost no Rad50 or Mre11 protein 
bands are visible. Marker (M), lysate (Lys), flow through (Flow), wash (Wash), fractions (A and B) 
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Figure 19: Fraction analyses after ÄktaFPLC purification with His-trap column. The Rad50 was eluted visibly after 
fraction A9 and decreased again after A12. The Mre11 is traceable from Fraction A9 till B15. Marker (M), Frac-
tions (A – B). 
 
5.1.3. Construction of a new C-terminally-tagged Mre11-Strep transfer vector 
In order to generate a transfer vector containing the full length Mre11 cDNA with an intact C-
terminal Strep-tag, the same cloning strategy was used that had already been used by Lucijana 
Pavic. This cloning strategy included three steps: since no baculovirus transfer vector containing 
a C-terminal Strep tag is commercially available, the cloning was started with the pEXPR-
IBA103 vector (IBA BioTAGnology) containing a C-terminal Strep-tag. The multiple cloning 
site (MCS) a Strep-tag sequence of pEXPR-IBA103 (Figure 20) was transferred into the pFast-
Bac1 vector of the Bac-to-Bac Baculovirus expression system from Invitrogen. In order to make 
the MCS of pEXPR-IBA a bit longer (which would facilitate the isolation of the DNA from an 
agarose gel) an insert with matching restriction sites from the vector pSG5-NBS1 was cloned in-
to pEXPR-IBA. Both pSG5-NBS1 and pEXPR-IBA were digested with XhoI restriction en-
zyme. The products of this reaction were separated on a 1% agarose gel and the bands of interest 
were cut out of the gel and purified with the NucleoSpin® Gel-Extraction Kit. Vector and insert 
were then ligated with T4 DNA ligase. The ligation reaction was afterwards transformed into 
XL1blue chemically competent E.coli cells. The plasmid DNA was then isolated by a miniprep-
aration and test digested with XhoI in order to verify the ligation success (Figure 21). 
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Figure 22: pFastBac1 vector map and multiple cloning sites 
(Reproduced from Bac-to-Bac manual from Invitrogen) 
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Figure 23: Test digestion of pFastBac-NBS1-Strep with BamHI/HindIII The vectors B, C, D, E, I, J, K have the 
Nbs1-Strep insert. Marker (Ma), minipreparations (A-N) 
 
The results in Figure 23 showed that the ligation was successful and thus, one clone (B) was 
chosen to perform the last step. In this step, full length Mre11 cDNA lacking the stop codon was 
excised from the pMGS3 vector with SalI and subsequently ligated into the pFastBac-Nbs1-
Strep vector where the Nbs1 insert was cut out with XhoI (note that XhoI and SalI produce com-
patible ssDNA overhangs). Again, the same procedure was used to ligate the vector and the in-
sert. For the control digestion, BamHI and EcoRI were used, because EcoRI cuts also within the 
open reading frame and thus, the orientation of the Mre11 cDNA could also be tested. After sev-
eral attempts the right fragment sizes were obtained (Figure 24). Two of these positive clones 4 
and 10 were sent for sequencing. 
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Figure 24: Test digestion of pFastBac-Mre11-Strep with BamHI/EcoRI. The vector 4, 6, 7, 10 have the predicted 
molecular weight (←). The two vectors were included undigested (*u) as negative controls. Marker (M), miniprepa-
rations (1-12). 
 
Unfortunately, the sequencing results showed that none of the constructs had the right sequence. 
Again, both the sequenced clones showed the same truncated C-terminal tag that we already ob-
served in the construct prepared by Lucijana Pavic. We concluded that this cloning strategy did 
not yield the expected results and decided to use another strategy. 
To minimize the error rate the first two steps of the above strategy were combined to a one step 
cloning procedure. The Strep-tag was directly excised of the vector pEXPR-IBA with BamHI 
and HindIII. Due to the small weight of the fragment it was purified on a 2% agarose gel. The 
Strep-tag fragment was then ligated into the pFastBac vector, which was also digested with 
BamH1/HindIII. XhoI and EcoRV digestion was used to verify the ligation success. The predict-
ed fragment sizes were 3500 and 1200 kb, respectively. The results in Figure 25 revealed that 
this ligation worked well and all selected clones were positive in the test digestion. To verify the 
result, three samples were sent for sequencing. 
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Figure 25: Test digestion of pFastBac-Strep Minipreparation with XhoI and EcoRV. All colonies were positive 
with the calculated piece size 3500 and 1200. Marker (M), minipreparations (1-10). 
 
The sequencing report showed that all selected clones had the right sequence. Therefore, the se-
cond step of the cloning was done with this new vector. The modified pFastBac vector was di-
gested with XhoI and purified. As described above, the Mre11 cDNA was excised from pMGS3 
with SalI and ligated into the modified pFastBac. Unfortunately, the test digestion showed that 
all the clones contained the insert in the wrong orientation (3’ to 5’) (Figure 26). 
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Figure 26: Test digestion of pFastBac-Mre11-Strep Minipreparation with BamHI and EcoRI. Vector 18 showed a 
similar hight like predicted, but its running pattern indicated that it might be empty vector. Marker (M), miniprepa-
rations (1-20). 
 
Therefore, we decided to change the cloning strategy completely. Instead of excising the Mre11 
cDNA from pMGS5 by using already existing restriction sites, we decided to insert a novel 5’ 
(upstream) restriction site by PCR. This restriction site (KpnI) is different from the 3’ (down-
stream) site and thus, the chance to isolate clones that contain the insert in the right orientation 
would increase significantly. 
 
In the first step the Strep-Tag was cut out of the pEXPR-IBA103 vector with HindIII/EcoRI to 
ligate it into the pFastBac1 vector. Since the EcoRI didn’t cut properly, test digestions were set 
up to find a working lot (data not shown). Since the test digestions used up a lot of pFastBac1 a 
Midi was done to get more DNA. Afterwards both vectors were again cut with EcoRI/HindIII 
(Figure 27/28). 
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Figure 27: Digestion of pEXPR-IBA103 (1) with HindIII and EcoRI. Strep-Tag at 160bp faint visible. Marker (M). 
 
 
Figure 28: Digestion of pFastBac1 (1) with HindIII and EcoRI. Marker (M). 
 
The fragments were gel purified and afterwards ligated and 10 Minipreparation with the new 
pFastBac1-Strep vector were done. These were digested with EcoRV and XbaI. The Miniprepa-
ration 6, 8, 9 and 10 showed the right digestion pattern (Figure 29), they were sent in for sequen-
zing. 6, 9 and 10 were positive, 8 couldn’t be read. The pFastBac1-Strep vector 6 was used for a 
Midi to get a higher amount of DNA. 
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Figure 29: Testdigestion of the Minipraparation of pFastBac1-Strep vector with EcoRV and XbaI. Marker (M), 
Minipreparation (1-10). 
In parallel the Mre11 was modified to contain a KpnI side. For this a PCR with the primers 
up_Mre11_Kpn1 and rev_PCR2.1_TOPO was run. The final product was then cut with KpnI 
and XhoI (Figure 30). 
 
Figure 30: Mre11-Kpn1 PCR. The PCR product was lost in the gel purification. Marker (M), pFastBac1 vector (1), 
PCR 1.5µl MgCl2 (2), PCR 3µl MgCl2 (3), PCR 5µl MgCl2 (4), PCR gel purification (5) 
 
The pFastBac1-Strep vector 6 was then cut with KpnI and XhoI, while the Mre11-KpnI was cut 
with KpnI and SalI. The resulting products were gelpurified and then ligated. The ligation was 
tested in 20 Minipreparations that were testdigested with KpnI and HindIII. From the positive 
clones (1000bp/1200bp) 2, 4 and 7 were sent in for sequenzing (Figure 31). All three had the 
correct sequence and clone 2 was used for the further experiments. 
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Figure 31: Testdigestion pFastBac-Mre11-Strep with KpnI/HindIII. The Minipreparations 2, 4, 5, 7, 8, 10, 11, 14, 
16, 20 are positive. Marker (M), Minipreparations (1-20). 
 
The recombinant pFastBac-Mre11-Strep was then used to transform the DH10Bac E. coli strain 
for transposition of the Strep-tagged recombinant Mre11 cDNA into the bacmid. For this the 
transformed bacteria were streaked out on Lb-agar plates containing kanamycin, gentamicin, tet-
racycline, x-gal and IPTG. A lot of colonies and satellites grew and it was difficult to distinguish 
between the blue and the white colonies. Therefore eleven colonies were picked for further anal-
ysis by PCR. This PCR analysis revealed that bacmid clones 5 and 7 contained the Strep-tagged 
Mre11 cDNA (Figure 32). Therefore bacmid clone 5 was used for the recombinant virus produc-
tion.  
 
Figure 32: Control PCR of the bacmid DNA. Bacmid clones 5 and 7 are positive. Marker (M), Minipreparations (1-
11). 
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5.1.4. Protein purification with the new vector 
The bacmid DNA was transfected into the SF21 insect cells. 3 different virus stocks were ac-
quired and the remaining cells were tested for Mre11 expression. A weak band was visible on a 
Coomassie blue stained gel with an apparent molecular mass that would fit that of Mre11 (Fig-
ure 33). 
 
Figure 33: Mre11-Strep transfection coomassie blue staining. Marker (M), negative control (0), bacmid transfected 
(1-3). 
 
Next, SF21 cells were infected with the three clones combined to amplify the virus. With the 
amplified virus stock, co-infection was performed with Mre11-Strep and Rad50-His viruses. 
Proteins were extracted with NP-40 buffer and purification was done over Ni-NTA resin and 
Streptavidin beads. Unfortunately, neither purification resulted in detectable amounts of purified 
protein on a Coomassie blue stained SDS gel (Figure 34). 
 
Figure 34: Amplification of Mre11-Strep and co-infection with Rad50-His. Faint band of Mre11 visible in the am-
plification and the extract. Marker (M), Amplification (Amp), Extract (Ex), Supernatant (SN), Wash (W), His-beads 
(His), Eluat (E1), Streptavidin beads (Strep). 
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Figure 35: Amplification of Mre11-Strep and co-infection with Rad50-His. The Rad50 antibody did not work, 
therefore the data is not shown. Mre11 binds not on the Streptavidin beads and is all lost in the supernatant 2. Mark-
er (M), Amplification (Amp), Extract (Ex), Supernant (SN), Wash (W), His-beads (His), Eluat (E1), Streptavidin 
beads (Strep). 
 
Therefore, in order to test if the expression was successful and the tagged proteins were binding 
to the affinity beads, a Western blot was performed with antibodies against Mre11 and Rad50, 
respectively. The Rad50 antibody did not reveal any bands (data not shown). The Mre11 anti-
body showed that very low levels of recombinant Mre11 was expressed (Figure 35), but did nei-
ther bind to the His beads nor to the Strep beads. Instead, all the protein remained in the superna-
tant fraction indicating that the protein was not capable to bind to the beads. At this point the 
project had to be abandoned due to time constraints and due to the fact that the host group of Dr. 
Manuel Stucki had left the IVBMB. 
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6. Discussion 
6.1. Purification of Mre11/Rad50-dimers using the Baculovirus expression 
system and tandem affinity purification 
The goal of this thesis was to purify MR dimers for single-particle EM and biochemical analysis. 
Previously, the lab expressed and purified Mre11/Rad50 proteins that were both tagged with His. 
As result a variability of products were obtained, Mre11 and Rad50 monomers, MR dimers and 
clumps (most likely aggregates of partially insoluble or not correctly folded protein) of different 
composition. The reason for this outcome most likely lies in the fact that both Mre11 and Rad50 
were equally affinity-tagged, which means that they would also bind to the same affinity matrix. 
Therefore, it was not possible to separate pure MR dimers from the monomers and probably also 
not from the aggregates of different composition. Thus, the idea of this project was to exchange 
the His tag on Mre11 to a Strep tag, which would allow tandem purification over different col-
umns and thus, isolation of pure MR dimers. A Strep-tagged Mre11 expression bacmid was al-
ready available in the lab so we started directly with the baculovirus production. The first diffi-
culty that came up here was that the SF21 cells were quite sensitive and tended to die fast, if the 
culture conditions were changed slightly. With more experience it was possible to increase the 
time in which the cells were in a condition that allowed performing experiments with them. The 
virus production went well and expression tests using the recombinant Mre11-Strep viruses re-
vealed detectable protein expression on a Western Blot. But since the titer of the Mre11-Strep vi-
rus stock was rather low, we decided to amplify the Mre11 virus first. With the amplified viruses 
an initial co-infection was done. The cells were harvested and extracted with NP-40 to extract 
the proteins from the cells. The extract was then run over nickel beads and then over Streptavi-
din beads. From each step aliquots were taken and loaded on a SDS-Gel. This analysis showed 
that the first purification worked well, even with little protein. But the second step did not work 
at all because all the recombinant protein was found in the flow through fraction, which indicat-
ed that the proteins did not bind to the beads efficiently. Because the protein concentration was 
really low from the beginning we assumed that this might have caused the binding problem. 
Therefore, it was decided to infect a larger number of cells and to do the purification with an 
ÄktaFPLC system. The first purification step on the ÄktaFPLC worked quite well, only the 
pressure indicator did not show any data, but since the extract wasn’t too viscous, we assumed 
that the pressure wouldn’t be too high. The other data curves (UV absorbance etc.) looked most-
ly as expected, only the protein peak in the elution fraction wasn’t as high as anticipated. 
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The eluate was then loaded on a SDS-PAGE for analysis. The results showed that different pro-
teins bound to the beads and that at the molecular weight position where Rad50 and Mre11 are 
expected to run, a faint band was visible. Western Blot analysis also showed that both Mre11 
and Rad50 proteins were expressed and bound to the His beads. The pooled protein fractions 
from the first purification step were incubated with Strep beads after dialysis and bound proteins 
were eluted with SDS-Page loading buffer. Analysis of this second purification step revealed 
that the recombinant Mre11 and Rad50 proteins were only detectable in the lysate and flow 
through, respectively. Western blot analysis confirmed these results. Since we also had Streptav-
idin-coated Dynabeads available, we tried to purify the MR dimers with them. Dynabeads are 
thought to be more inert and to bind more protein than Strep agarose. But we essentially got the 
same results with them. 
One possibility was that the protein concentration was too low in the eluate of the first purifica-
tion step. Another possibility we considered was that the Strep tag sequence was either wrong or 
for some reasons not accessible (maybe due to sterical hindrance). 
Therefore, the purification with a larger amount of extract was repeated and the Mre11-Strep 
transfer vector was sent for sequencing. The second purification showed very similar results as 
the first one. Moreover, the sequencing results revealed that the Strep-tag on Mre11 was indeed 
faulty. It comprised only a few amino acids, followed by a premature stop codon. This construct 
would lead to the expression of full length Mre11 without an affinity tag and thus explains our 
result that no recombinant protein was binding to the Strep beads. 
It was then decided to start from scratch and generate a new Mre11 bacmid with the correct tag 
sequence at its C-terminus. 
The insertion of the Mre11 cDNA into pFastBac1 together with the addition of a C-terminal 
Strep tag caused various difficulties. The biggest problem was that the Mre11 cDNA preferen-
tially inserted into the vector in the wrong orientation (3’ – 5’). Different conditions were tried 
(vector insert ratios) but with no positive results. Therefore the strategy was changed and PCR 
was used to amplify the Mre11 cDNA and at the same time induce new restriction sites flanking 
the cDNA to insert it in the right position in front of the Strep tag. This eventually worked and 
two bacmid clones with the correct sequence could be isolated. Unfortunately though, we were 
not able to express Mre11 protein that bound to the Strep-affinityresin with this bacmid, even 
though it had the correct sequence. One possible reason for this is that the amounts of recombi-
nant protein expressed by our recombinant baculoviruses were extremely low. It could barely be 
detected by Western blot and we didn’t detect the protein on Coomassie blue stained SDS gels. 
It is a known fact that low protein concentration can cause problems during purification. Unfor-
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tunately, time didn’t allow to optimize recombinant protein expression because the host group of 
Dr. Manuel Stucki moved to a different institute at the University Hospital Zürich. 
In summary, even though the primary goal of this thesis could not be achieved due to technical 
difficulties and time constraints, it was nevertheless managed to correct the faulty Mer11-strep 
clone and to generate a Mre11-strep bacmid with the correct sequence. This new bacmid could 
now be used to optimize expression conditions to eventually isolate pure MR dimers for EM 
analysis. 
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7. Abbreviations 
α   Anti 
bp   Base pairs 
BSA   Bovine serum albumine 
CIP   Calf intestine phosphatase 
DDR   DNA damage response 
DMSO  Dimethyl sulfoxide 
DNA   Deoxyribonucleic acid 
dNTP   Deoxyribonucleosidetriphosphat 
ds   Double stranded 
DSB   DNA double-strand break 
ECL   Enhanced chemiluminescence 
E.coli   Escherichia Coli 
EDTA   Ethylendimin-tetraacetic acid 
FCS   Fetal calf serum 
FPLC   Fast protein liquid chromatography 
HEPES  4-(Hydroxyethyl) Piperazine-1-ethanesulonic acid 
HR   Homologous recombination 
HRP   Horseradish peroxidase 
IPTG   Isopropyl-β-D-thiogalactopyranosid 
LB-medium Luria-Bertani-medium 
MRE11  Meiotic recombination 11 protein 
MRN-complex Mre11-RAD50-NBS1-complex 
NBS1   Nijmegen Breakage Syndrome 1 protein 
NHEJ   Non-homologues end joining 
NP40   Nonidet P40 
OD   Optical Density 
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PCR   Polymerase chain reaction 
PBS   Phosphate buffered saline 
RAD50  Radiation sensitive yeast 50 
rpm   Rounds per minute 
ss   Single stranded 
SDS-PAGE Sodium dodecylsulfate – polyacrylamid electrophotesis 
SF21   Spodoptera frugiperda 21 
TEMED  N,N,N’,N’-Tetramethylethylendiamin 
Tris   Tris-(hydroxymethyl)-aminomethan 
UV   Ultraviolet 
X-gal   bromo-chloro-indolyl-galactopyranoside 
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9. Appendix 
9.1. Buffers, medias and solutions 
Blue Dye  1ml Bromphenol blue 
   0.5 ml β-mercapto-ethanol (14.2M) 
   add dH2O to 10ml 
 
Buffer 1  50mM Tris pH 7.0 
   0.5M NaCl 
   0.5% NP40 
   20mM Imidazole (10μl) 
 
Buffer 2  50mMTris pH 7.0 
   0.5M NaCl 
   0.5% NP40 
   50-200mM Imidazol (100μl) 
 
Buffer 3  50mM Tris pH 7.0 
   0.5M NaCl 
 
Buffer A  249.375ml 1x PBS 
   0.5ml NaCl (5M) 
   0.125ml Triton 100 
 
Buffer B  186.875ml 1x PBS 
   0.5ml NaCl (5M) 
   0.125ml Triton 100 
   62.5ml Imidazole (2M) 
 
Buffer C  99.75ml 1x PBS 
   0.2ml NaCl (5M) 
   50μl Triton 100 
 
Buffer D  99.55ml 1x PBS 
   0.4ml NaCl (5M) 
   50μl Triton 100 
 
Destain   400ml MetOH 
   10ml Acetic Acid 
   add dH2O to 1000ml 
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Extraction buffer A 50mM Tris pH7.0 
   0.25M NaCl 
   0.5% NP40 
   10% Glycerol 
   1mM DTT 
 
LB medium (Luria-Bertani medium) 10g Bactotryptone 
   5g Bacto-yeast extract 
   10g NaCl 
   in 1l dH2O 
   adjust pH to 7.0 with NaOH 
 
Lysis Buffer  99.25ml 1x PBS 
   0.2ml NaCl (5M) 
   50μl Triton 100 
   0.5ml Imidazole (2M) 
 
6x Loading buffer 30ml Glycerol (87%) 
   0.5g Bromphenol blue 
   0.5g Xylen Cynol 
   add dH2O to 200ml 
 
1kb Marker  30μl 1kb Marker 
   6x loading buffer 
   add dH2O to100μl 
 
10x PBS (Phosphate-buffered saline) 80g NaCl 
   2g KCl 
   14.4g Na2HPO 
   2.4g KH2PO 
   add dH2O to 1l 
   adjust pH to 7.4 with HCl 
 
Ponceau S  2g Ponceau S 
   30g Trichloridacid 
   30g Sulfatsalicyl acid 
   add dH2O to 100ml 
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2x Running-gel buffer 150ml Tris (1M, pH 8.8) 
   2ml SDS (20%) 
   add dH2O to 200ml 
 
10x Running buffer 60.6g Tris 
   288.2g Glycin 
   add dH2O to 2l 
 
20% SDS  40g SDS 
   add dH2O to 200ml 
 
2x SDS loading buffer 1ml Tris (1M, pH 6.8) 
   50μl β-mercapto ethanol 
   2ml SDS (20%) 
   200μl Bromphenol blue 
   2ml Glycerol (87%) 
 
SOB   20g Bacto-Trypton 
   5g Bacto-yeast extract 
   0.5g NaCl 
   add dH2O to 1000ml 
   10ml KCl (250mM) 
   adjust pH to 7.0 with NaOH 
   5ml MgCl2 (5M) just before use 
 
SOC   980ml SOB 
   10ml MgSO4 
 
Stacking-gel buffer 30.2ml Tris (1M, pH.8) 
   1.2ml SDS (20%) 
   add dH2O to 200ml 
 
Stain   0.25g Coomassie Brilliant Blue R250 
   100ml MeOH 
   25ml Acetic acid 
   add dH2O to 250ml 
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1x TAE buffer 4.84g Tris 
   1.14g Gluacal acetic acid 
   2ml EDTA (0.5M, pH8) 
   add H2O to 1000ml 
 
TB buffer  5ml Hepes (0.5M, pH 6.7) 
   3.75ml CaCl2 (1M) 
   25ml KCl (2.5M) 
   add dH2O to 250ml 
   adjust pH to 6.7 with KOH 
   add 27.5ml MnCl2 (0.5M) before use 
 
1x TBS buffer 12.1g Tris 
   97.7g NaCl 
   add H2O to 1000ml 
 
TBS-T   1l TBS 
   0.5ml Tween 20 
 
Transfer buffer 100ml Running buffer (10%) 
   200ml Methanol 
   add dH2O to 1l 
 
9.1. Primers and oligonucleotides 
M13_for 
5`-GTT TTC CCA GTC ACG AC -3` 
M13_rev 
5`-CAG GAA ACA GCT ATG AC -3` 
Up_Mre11_BamH1 
5’-CGG GAT CCA TGA GTA CTG CAG ATG CAC TTG ATG-3’ 
rev_pCR2.1_TOPO 
5’-GTA AAA CGA CGG CCA GTG AAT TGT AAT ACG-3’ 
Up_Mre11_Kpn1 
CGGGTACCATGAGTACTGCAGATGCACTTGATG 
 
  
9.2. 
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